Brown, Lisle/Cummings, Inc. Ark Genomic Revolution ETF (De Transaction History
Brown, Lisle/Cummings, Inc.
- $335 Billion
- Q4 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 400 shares of ARKG stock, worth $9,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 379
5.54%
Holding current value
$9,100
Previous $9.7 Million
2.93%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARKG
# of Institutions
288Shares Held
23.4MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$82.5 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$79.3 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$63.5 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$63.3 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$37.7 Million0.02% of portfolio